Dominican patients must wait an average of nearly six years to access innovative medications already available elsewhere. A report highlights that this delay is longer than the Latin American average and sheds light on the obstacles that hinder access to new therapies, particularly in the field of oncology. This situation is compounded by low health investment in the country, worsening the issue.